Pereira M, Jeyabalan J, Jrgensen CS, et al
Discontinuation of treatment or switching between agents should be reserved for patients with persistent or severe symptoms despite optimised management strategies
The drug semaglutide GLP-1 stimulates the release of glucagon-like peptide-1 (GLP-1) Orally or by injection, semaglutide GLP-1 increases the production of insulin, a hormone produced by the pancreas that helps regulate blood sugar levels
Insulin Sensitivity: These medications improve insulin sensitivity, leading to better blood sugar control, which helps reduce fat storage
Published in 2016, the study showed that liraglutide reduced the risk of cardiovascular disease which is one of the most common causes of death in patients with type 2 diabetes
injectables remaining the clinical gold standard for moderate-to-severe obesity